PharmaCyte Biotech, Inc.
Reporting owner on Forms 3, 4 and 5, CIK 1157075.
PharmaCyte Biotech, Inc. reported on 1 issuer in 2 filings, the latest a 13D/A filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| QCLS · Q/C TECHNOLOGIES, INC.CIK 1321834 | 10% owner | 1 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| QCLS · Q/C TECHNOLOGIES, INC.Common stock | 2026-11-18 | X exercised | +4,982,272 | $0 | 5,152,000 | Form 4 |
| QCLS · Q/C TECHNOLOGIES, INC.Series G Long-Term Warrants, derivative | 2026-11-18 | X exercised | -851,304 | $0 | 13,318,344 | Form 4 |
| QCLS · Q/C TECHNOLOGIES, INC.Series H Convertible Preferred Stock, derivative | 2026-11-18 | J other | +3,000 | $0 | 3,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13D/A 0001683168-26-009020 | QCLS | 2026-11-20 | ||
| Form 4 0001683168-26-009018 | Q/C TECHNOLOGIES, INC. | 2026-11-20 |